About: CpG Oligodeoxynucleotides Protect Normal and SIV-Infected Macaques from Leishmania Infection

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: CpG Oligodeoxynucleotides Protect Normal and SIV-Infected Macaques from Leishmania Infection Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 May 2003

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в травні 2003 (uk) im Mai 2003 veröffentlichter wissenschaftlicher Artikel (de) article scientifique publié en 2003 (fr) artículu científicu espublizáu en mayu de 2003 (ast) scientific article published on 01 May 2003 (en)
publication date	wds:Q61708148-7568E06D-C398-4DB8-94DA-1D746394DA6B
publication date	2003-05-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q61708148-1231C157-57AF-4D60-AEFD-4D0F9810C287
language of work or name	English
author name string	wds:Q61708148-4CDDCB6E-322F-4B2A-9BCC-51EE0B316290 wds:Q61708148-95D754F3-50DF-47DB-BD69-7960863B2068 wds:Q61708148-EC2103E3-80A2-4EDA-87C2-BE2222766E24 wds:Q61708148-ED33DAAE-83BD-432E-BF96-85C99910A4FE wds:Q61708148-F4B2C8F3-698D-4F8F-B859-CC3DB8B1255A wds:Q61708148-F818E425-599A-445C-8E3B-14FF3FA1C97A
author name string	Shuying Liu Jeffrey D Lifson Dennis M Klinman Daniela Verthelyi Richard T Kenney Joan Mican
rdfs:label	CpG Oligodeoxynucleotides Protect Normal and SIV-Infected Macaques from Leishmania Infection (en) CpG Oligodeoxynucleotides Protect Normal and SIV-Infected Macaques from Leishmania Infection (nl)
skos:prefLabel	CpG Oligodeoxynucleotides Protect Normal and SIV-Infected Macaques from Leishmania Infection (en) CpG Oligodeoxynucleotides Protect Normal and SIV-Infected Macaques from Leishmania Infection (nl)
name	CpG Oligodeoxynucleotides Protect Normal and SIV-Infected Macaques from Leishmania Infection (en) CpG Oligodeoxynucleotides Protect Normal and SIV-Infected Macaques from Leishmania Infection (nl)
author	wds:Q61708148-91D68BEB-CD23-463E-B817-6C6FBABB6D78
author	Mayda Gürsel
title	wds:Q61708148-896B34A4-4E6C-46FA-8864-B4DB49AF2BEB
title	CpG oligodeoxynucleotides protect normal and SIV-infected macaques from Leishmania infection (en)
page(s)	wds:Q61708148-E869A193-E6AC-41C5-80F8-24B79148E729
page(s)	4717-4723
instance of	wds:Q61708148-3A7C808A-9406-4E14-9D81-49F4A8A0CE80
instance of	scholarly article
PubMed ID	wds:Q61708148-1D7202B1-5085-4925-855E-7CF5CF56C6E0
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/12707351
PubMed ID	12707351
published in	wds:Q61708148-02CBF961-1F04-4782-91CA-4301322C341A
published in	Journal of Immunology
issue	wds:Q61708148-6DCFF4D5-50D0-417D-A4BE-26A873D30958
volume	wds:Q61708148-EDE63A9B-2620-4B7D-8C29-C0C4D8D847DC
issue	9
volume	170
DOI	wds:Q61708148-8F38CBE3-EE83-4894-91F1-DF59E1471ECE
DOI	http://dx.doi.org/10.4049/JIMMUNOL.170.9.4717
DOI	10.4049/JIMMUNOL.170.9.4717
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q61708148
is cites work of	Deoxycytidyl-deoxyguanosine oligonucleotide classes A, B, and C induce distinct cytokine gene expression patterns in rhesus monkey peripheral blood mononuclear cells and distinct alpha interferon responses in TLR9-expressing rhesus monkey plasmacyto Immunotherapeutic uses of CpG oligodeoxynucleotides CpG oligodeoxynucleotide and Montanide ISA 51 adjuvant combination enhanced the protective efficacy of a subunit malaria vaccine Immunomodulatory effects associated with a live vaccine against Leishmania major containing CpG oligodeoxynucleotides A CpG oligonucleotide can protect mice from a low aerosol challenge dose of Burkholderia mallei TLR-based immune adjuvants. CpG DNA as a vaccine adjuvant. Therapeutic potential of Toll-like receptor 9 activation The Toll-like receptor 7 (TLR7) agonist, imiquimod, and the TLR9 agonist, CpG ODN, induce antiviral cytokines and chemokines but do not prevent vaginal transmission of simian immunodeficiency virus when applied intravaginally to rhesus macaques Innate immune activation as a broad-spectrum biodefense strategy Prospects and research challenges Innate immunity for biodefense: a strategy whose time has come Impaired monocyte maturation in response to CpG oligodeoxynucleotide is related to viral RNA levels in human immunodeficiency virus disease and is at least partially mediated by deficiencies in alpha/beta interferon responsiveness and production Immunoregulatory activity of CpG oligonucleotides in humans and nonhuman primates Developing animal models for polymicrobial diseases CpG ODNs treatments of HIV-1 infected patients may cause the decline of transmission in high risk populations - a review, hypothesis and implications. Novel therapeutic strategies based on toll-like receptor signaling Broad-Spectrum Drugs Against Viral Agents Local and systemic B cell and Th1 responses induced following ocular mucosal delivery of multiple epitopes of herpes simplex virus type 1 glycoprotein D together with cytosine-phosphate-guanine adjuvant Activation of innate immunity in healthy Macaca mulatta macaques by a single subcutaneous dose of GMP CpG 7909: safety data and interferon-inducible protein-10 kinetics for humans and macaques Antiinfective applications of toll-like receptor 9 agonists Differential Immune Response against Recombinant Leishmania donovani Peroxidoxin 1 and Peroxidoxin 2 Proteins in BALB/c Mice Association of self-DNA mediated TLR9-related gene, DNA methyltransferase, and cytokeratin protein expression alterations in HT29-cells to DNA fragment length and methylation status. CpG oligodeoxynucleotides increase the susceptibility of normal mice to infection by Candida albicans Disparate effects of acute and chronic infection with SIVmac239 or SHIV-89.6P on macaque plasmacytoid dendritic cells Prevention and treatment of cutaneous leishmaniasis in primates by using synthetic type D/A oligodeoxynucleotides expressing CpG motifs Use of thermolytic protective groups to prevent G-tetrad formation in CpG ODN type D: structural studies and immunomodulatory activity in primates Prophylactic application of CpG oligonucleotides augments the early host response and confers protection in acute melioidosis Hypothesis links emergence of chloroquine-resistant malaria and other intracellular pathogens and suggests a new strategy for treatment of diseases caused by intracellular parasites In ovo administration of CpG oligodeoxynucleotides and the recombinant microneme protein MIC2 protects against Eimeria infections Organosilane and Polyethylene Glycol Functionalized Magnetic Mesoporous Silica Nanoparticles as Carriers for CpG Immunotherapy In Vitro and In Vivo Prodrugs for the treatment of neglected diseases. Trace levels of innate immune response modulating impurities (IIRMIs) synergize to break tolerance to therapeutic proteins Development of Nonaggregating Poly-A Tailed Immunostimulatory A/D Type CpG Oligodeoxynucleotides Applicable for Clinical Use. How to master the host immune system? Leishmania parasites have the solutions! Immunostimulatory oligodeoxynucleotides are potent enhancers of protective immunity in mice immunized with recombinant ORFF leishmanial antigen. Immunomodulatory consequences of ODN CpG-polycation complexes Synthetic innate defence regulator peptide enhances in vivo immunostimulatory effects of CpG-ODN in newborn piglets Short- and long-term changes in gene expression mediated by the activation of TLR9 Preconditioning with intravenous colitic cell-free DNA prevents DSS-colitis by altering TLR9-associated gene expression profile DCs facilitate B cell responses against microbial DNA via DC-SIGN. CpG ODN D35 improves the response to abbreviated low-dose pentavalent antimonial treatment in non-human primate model of cutaneous leishmaniasis Carbonate Apatite Nanoparticles Act as Potent Vaccine Adjuvant Delivery Vehicles by Enhancing Cytokine Production Induced by Encapsulated Cytosine-Phosphate-Guanine Oligodeoxynucleotides.
is cites work of	wds:Q33788621-D2E6EA24-65ED-4676-8894-DEAC07DCD21B wds:Q36035026-EF268F4F-147C-4C57-857B-F654085C95F2 wds:Q36501229-24861B7E-5F09-4397-A8EF-EA65B3DA2A64 wds:Q36868322-3C7E4328-B298-49AF-BED9-5EACDB06F697 wds:Q35225487-7C6BBAC6-7DFA-4B03-AB8C-4D2F73C4CE5B wds:Q41914491-FA319E24-E445-4228-8AE3-8785E80A8E59 wds:Q45534569-8A69A9FF-1EA2-4708-AB32-A1764E79F1C0 wds:Q40433859-FE53DF30-6A5A-4A0A-B535-E08713837B83

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 193 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software